Matilda Holm

Article: CANCER RESEARCH. 2022;82(19):3549-3560

Systematic Comparison of Pancreatic Ductal Adenocarcinoma Models Identifies a Conserved Highly Plastic Basal Cell State.

Pitter KL; Grbovic-Huezo O; Joost S; Singhal A; Blum M; Wu K; Holm M; Ferrena A; Bhutkar A; Hudson A; Lecomte N; de Stanchina E; Chaligne R; Iacobuzio-Donahue CA; Pe'er D; Tammela T

Article: PLOS ONE. 2022;17(5):e0267967

Quantitative glycoproteomics of human milk and association with atopic disease.

Holm M; Saraswat M; Joenväärä S; Seppo A; Looney RJ; Tohmola T; Renkonen J; Renkonen R; Järvinen KM

Article: PLOS ONE. 2022;17(8):e0272810

Quantitative bile and serum proteomics for the screening and differential diagnosis of primary sclerosing cholangitis.

Holm M; Joenväärä S; Saraswat M; Tohmola T; Saarela T; Tenca A; Arola J; Renkonen R; Färkkilä M

Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2020;117(48):30670-30678

Unbiased in vivo preclinical evaluation of anticancer drugs identifies effective therapy for the treatment of pancreatic adenocarcinoma.

Grbovic-Huezo O; Pitter KL; Lecomte N; Saglimbeni J; Askan G; Holm M; Melchor JP; Chandwani R; Joshi S; Haglund C; Iacobuzio-Donahue CA; Chiosis G; Tammela T; Leach SD

Article: CANCER MEDICINE. 2020;9(14):5221-5234

Plasma protein expression differs between colorectal cancer patients depending on primary tumor location.

Holm M; Joenväärä S; Saraswat M; Tohmola T; Ristimäki A; Renkonen R; Haglund C

Article: TUMOR BIOLOGY. 2020;42(6):1010428320936410-101042832093641

Label-free proteomics reveals serum proteins whose levels differ between pancreatic ductal adenocarcinoma patients with short or long survival.

Holm M; Saraswat M; Joenväärä S; Seppänen H; Renkonen R; Haglund C

Article: PLOS ONE. 2020;15(6):e0235478

Describing the status of reproductive ageing simply and precisely: A reproductive ageing score based on three questions and validated with hormone levels.

Triebner K; Johannessen A; Svanes C; Leynaert B; Benediktsdóttir B; Demoly P; Dharmage SC; Franklin KA; Heinrich J; Holm M; Jarvis D; Lindberg E; Rovira JMM; Muniozguren Agirre N; Sánchez-Ramos JL; Schlünssen V; Skulstad SM; Hustad S; Rodriguez FJ; Gómez Real F

Article: PLOS ONE. 2020;15(11):e0239819

Detection of KRAS mutations in liquid biopsies from metastatic colorectal cancer patients using droplet digital PCR, Idylla, and next generation sequencing.

Holm M; Andersson E; Osterlund E; Ovissi A; Soveri L-M; Anttonen A-K; Kytölä S; Aittomäki K; Osterlund P; Ristimäki A

Article: PLOS ONE. 2020;15(6):e0234989

N-glycomic profiling of colorectal cancer according to tumor stage and location.

Holm M; Nummela P; Heiskanen A; Satomaa T; Kaprio T; Mustonen H; Ristimäki A; Haglund C

Article: ONCOLOGY. 2020;98(7):493-500

Preoperative Radiotherapy Leads to Significant Differences in the Plasma Protein Profile of Rectal Cancer Patients.

Holm M; Joenväärä S; Saraswat M; Tohmola T; Ristimäki A; Renkonen R; Haglund C

Article: FASEB BIOADVANCES. 2019;1(12):723-730

Identification of several plasma proteins whose levels in colorectal cancer patients differ depending on outcome.

Holm M; Joenväärä S; Saraswat M; Mustonen H; Tohmola T; Ristimäki A; Renkonen R; Haglund C

Article: PLOS ONE. 2018;13(4):e0195354

Colorectal cancer patients with different C-reactive protein levels and 5-year survival times can be differentiated with quantitative serum proteomics.

Holm M; Saraswat M; Joenväärä S; Ristimäki A; Haglund C; Renkonen R

Artiklar

Nyheter från KI

Kalenderhändelser från KI